Guidance on Implementability
This document provides guidance on the planning, design and conduct and reporting of clinical trials, so that the results from late-phase clinical trials are optimised for implementability.
Consumer Involvement and Engagement Toolkit
The Consumer Involvement and Engagement Toolkit provides practical advice for researchers and research organisations wishing to conduct patient-centred clinical trials.
We’ve created this area for COVID-19 information relevant to clinical trials. In line with the national guidance and emphasis on the safety and well-being of patients, research participants and their families, and health care professionals, researchers and other staff involved in patient care and research, ACTA strongly supports the continuation of investigator-led trials, where it is safe to do so, and with due consideration to any protocol amendments appropriate for the current COVID-19 pandemic.
General search and filters
Type of Resource
Results filtered by:
Official Opening of the 2020 ACTA Summit: Minister’s Address
Data and Safety Monitoring Boards Webinar Series: Statistical Principles
Data and Safety Monitoring Boards Webinar Series: How to plan well and be prepared for the unexpected
AAAPC Conference: ACTA Workshop Minutes
Statistical Analysis Plan
External Contractor Tender: Application of altered or waived consent approaches in low risk clinical trials
Improving impact of clinical trials through implementability
ACTA Board Charter
Registry Randomised Trial Workshop Biographies
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
Applying a proportionate approach to consent in comparative effectiveness trials